JPRN-UMIN000015849招募中未知
Phase I/II study of S-1, docetaxel, oxaliplatin combination chemotherapy (DOS) in patients with HER2-negative unresectable metastatic gastric cancer - Phase I/II study of S-1, docetaxel, oxaliplatin combination chemotherapy (DOS) in patients with HER2-negative unresectable metastatic gastric cancer
Department of Gastroenterology and Oncology0 个研究点目标入组 59 人开始时间: 2014年12月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 59
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)History of hypersensitivity to DCS. 2)Contraindication to Oxaliplatin, CDDP, S-1, G-CSF. 3)Infectious disease. 4)Severe compliaction. 5)Neuropathy greater than grade 2. 6)Brain metastasis with clinical symptoms. 7)Watery diarea. 8)Active double cancer. 9)Persons to be pregnant or to make pregnant.
研究者
相似试验
招募中
1 期
DOS studygastric cancerJPRN-jRCTs061180095Takayama Tetsuji30
已完成
1 期
Phase 1 study of Docetaxel and Oxaliplatin and TS-1 for unresectable / recurrent gastric cancer (KOGC-06)unresectable / recurrent gastric cancerJPRN-UMIN000015723Keio University School of Medicine, Department of Surgery5
已完成
1 期
Phase I/II Study of S-1, Cisplatin and Docetaxel in Patients with Advanced Gastric Canceruntreated advanced or recurrent gastric cancerJPRN-UMIN000000484Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama40
已完成
2 期
Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric CancerStomach NeoplasmsNCT00525005Hallym University Medical Center44
已完成
1 期
Phase I study of Docetaxel, Cisplatin and S-1 in patients with advanced or recurrent gastric cancerGastric cancerJPRN-UMIN000000978Shizuoka Cancer Center18